Abstract

Chronic obstructive pulmonary disease (COPD) is induced by cigarette smoking and characterized by inflammation of airway tissue. Since smokers with COPD have a higher risk of developing lung cancer than those without, we hypothesized that they carry more mutations in affected tissue. We called somatic mutations in airway brush samples from medium-coverage whole genome sequencing data from healthy never and ex-smokers (n = 8), as well as from ex-smokers with variable degrees of COPD (n = 4). Owing to the limited concordance of resulting calls between the applied tools we built a consensus, a strategy that was validated with high accuracy for cancer data. However, consensus calls showed little promise of representing true positives due to low mappability of corresponding sequence reads and high overlap with positions harbouring known genetic polymorphisms. A targeted re-sequencing approach suggested that only few mutations would survive stringent verification testing and that our data did not allow the inference of any difference in the mutational load of bronchial brush samples between former smoking COPD cases and controls. High polyclonality in airway brush samples renders medium-depth sequencing insufficient to provide the resolution to detect somatic mutations. Deep sequencing data of airway biopsies are needed to tackle the question.

Highlights

  • Chronic obstructive pulmonary disease (COPD) is induced by cigarette smoking and characterized by inflammation of airway tissue

  • The increased number and unusual distribution of calls could have been related to a local Epstein-Barr virus (EBV) infection (Supplementary Methods and Supplementary Fig. S1B), which can enhance mutational loads[35]

  • We were unable to detect a robust number of somatic single-nucleotide mutations (SSMs) in this study, neither in lung brushings of former smokers in general, nor in COPD patients

Read more

Summary

Introduction

Chronic obstructive pulmonary disease (COPD) is induced by cigarette smoking and characterized by inflammation of airway tissue. We called somatic mutations in airway brush samples from medium-coverage whole genome sequencing data from healthy never and ex-smokers (n = 8), as well as from ex-smokers with variable degrees of COPD (n = 4). WGS of intermediate read depth proved suitable for somatic mutation calling (SMC) in prostate tissue distant to clinically overt tumours, whereby many mutations were found that were neither present in the tumour nor in the blood representing the germline genome[13] This indicates clonal expansion adjacent to a tumour in morphological normal prostate tissue and has been observed in several other tissues including lung[14]. We leveraged medium-coverage WGS data of lower lobe epithelial lung tissue, isolated from airway brushings, and blood as reference tissue from 12 elderly individuals to identify somatic single-nucleotide mutations (SSMs) and compared the total mutational load with respect to smoking status (ex-smokers vs never smokers) and presence of COPD (within ex-smokers). Verification analysis of the mutation calls resulted in a surprisingly small set of confirmed SSMs arguing for a highly polyclonal cell mixture in brush samples

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call